FDA Inspection 971948 — Oklahoma Blood Institute Southern

Oklahoma Blood Institute Southern — FEI 1629859

The FDA completed an inspection of Oklahoma Blood Institute Southern on March 11, 2016 in Ardmore, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ardmore, OK (United States)